As of Feb 2, 2023, Meridian Bioscience Inc. has 4 shares failed to deliver, representing 0.00% of the average daily volume of 686,607 shares. Over the past year, the monthly average FTD is 584 shares, with the current level 99% below the historical average, indicating low settlement pressure. The weighted FTD ratio below 1% suggests normal market making activity with adequate liquidity.